Giorgio Scagliotti, MD
University of Turin San Luigi Hospital
1
1
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Marc Fellous, MD
Sr. Vice President, Clinical Development and Medical Affairs
Shared therapeutic areas:
Joel W Neal, MD, PhD
Stanford University
Shared therapeutic areas:
Akin Atmaca, PD Dr. med.
Krankenhaus Nordwest, Frankfurt, Deutschland
Shared therapeutic areas:
Ningbo Liu, Doctor
Tianjin Medical University Cancer Institute and Hospital
Shared therapeutic areas:
Joachim von Pawel, MD
Askelios Klinik München Gauting
Shared therapeutic areas:
Yin Cheng, Professor
Jilin Provincial Tumor Hospital
Shared therapeutic areas:
Xuan Zhao, Ph.D.
JenKem Technology Co., Ltd.
Shared therapeutic areas:
Padma Yerramilli-Rao, MB BS, PhD
Treeline Biosciences, Inc.
Shared therapeutic areas:
Gilbert Youssef, MD
Dana-Farber Cancer Institute
Shared therapeutic areas:
Muhhamad Furqan, MD
University of Iowa
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
All 1 trials loaded